← Evidence map

ArticleVaccine2023

Effectiveness of second booster compared to first booster and protection conferred by previous SARS-CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France.

Cynthia Tamandjou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36964001